By functional cloning, we have established that Ran GTPase is involved in L
PS-induced signal transduction. This has been accomplished by several funct
ional comparisons of the two cDNAs, Lps(n)/Ran (or RanT/n) and Lps(d)/Ran (
or RanC/d), which were isolated from cDNA libraries of LPS responder and hy
poresponder mice, respectively. The letter n refers to the 'normal' phenoty
pe and the letter d refers to the 'deficient' phenotype. Consistent with ou
r previous results, more animal studies indicated that adenoviral transduct
ion of RanC/d cDNA, but not RanT/n cDNA, into sensitive mice conferred sign
ificant resistance against endotoxin challenge. Thus the incorporation of R
anC/d cDNA into gene therapy protocols as a therapeutic sequence remains ve
ry attractive. At steady state, hematopoietic cells transduced with RanC/d
cDNA led to about a IO-fold increase in exogenous Ran protein compared with
RanT/n cDNA. Furthermore, our cumulative data suggest that a slight elevat
ion of Ran protein in B cells enhances LPS responsiveness, but the same ele
vation of Ran in macrophages does not. On the other hand, a high level of o
verexpression of Ran in both macrophages and B cells down-regulates LPS sig
nal transduction. Thus LPS-induced signal transduction in macrophages and B
cells is likely to occur via different signaling pathways.